Monografie
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
- Sprache
-
Englisch
- Umfang
-
XI, 172 Blätter
- Identifier
-
1119086221
- Thema
-
Krebs ; Vaccinia-Virus; Glioblastom; Hochschulschrift
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Der Zugriff auf Teile des Objekts ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.04.2024, 08:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
Ähnliche Objekte (12)
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines